BACE1 and Alzheimer disease: A PEG-based polymeric formulation was conjugated with galactose to enhance brain delivery of anti-BACE1 siRNA against Alzheimer’s disease, based on the observation that D-glucose and D-galactose are both substrates of GLUT1 [68].